Aurobindo Pharma plans to launch 200 products in Europe
The Dollar Business Bureau Drug manufacturing company Aurobindo Pharma Ltd is planning to launch around 200 products in the European market in the coming four years in order to enhance the product portfolio of the company. “The next lever of growth will come from new products which are being developed. Currently, we have almost 200 products under development for Europe alone and that will be launched over next three to four years,” Sanjeev Dani, COO & Head Formulations, Aurobindo Pharma told analysts. That will be the growth driver in the Europe, he added. In the first quarter of the fiscal 2016-17, the formulations sales of the company in Europe stood at Rs.831.2 crore witnessing a growth of 12.1 percent year-on-year. In the segment of formulations, the EU market ...
'Indian nutraceutical industry yet to explore export avenues'
Sai Nikesh | The Dollar Business Global nutraceutical market is expected to cross $262.9 billion by 2020 from the current level of $182.6 billion, growing by 8% annually, a study be Associated Chamber of Commerce and Industry (ASSOCHAM) has claimed. Changing lifestyle and rising health awareness is expected to boost Indian market too and the country’s nutraceutical market is likely to cross $6.1 billion by 2020 from the current level of $2.8 billion growing at the compound annual growth rate of about 17%, said the study titled ‘Indian Nutraceuticals, Herbals, and Functional Foods Industry: Emerging on Global Map’. Experts feel that even though there is a huge development scope, few challenges are hindering growth of the Indian Nutraceutical Industry. “India is having ...
